The company is currently focused on two areas of development:

​

1. Finalizing the prototype test and launching telomere profiling test services for the telomere research community, especially large-scale human population studies and clinical trials. Our innovative, cost-effective tools will advance understanding of telomere biology in aging and disease, while accelerating the development of pharmaceutical products targeting telomere maintenance pathways.​

​

2. Developing telomere profiling tests to improve the diagnosis of inherited telomere diseases, such as Idiopathic Pulmonary Fibrosis (IPF) and Telomere Biology Disorders (TBD).